Andrew Wilks
CO-FOUNDER
SYNkinase
Australia
Biography
Andrew Wilks PhD has been involved as a scientist in pharmaceutical drug discovery for 3 decades, most recently as Chief Scientific Officer and founder of Cytopia. Prior to starting Cytopia, Andrew was an accomplished scientist at the Ludwig institute for Cancer Research in Melbourne where he discovered the JAK kinases and published 1 book, 86 peer reviewed publications, and 35 patents and patent applications. Andrew is a member of the board and/or scientific advisory board of a number of research companies, holds an Honorary Professorship in the Department of Medicine, Nursing and Health Sciences at Monash University (Melbourne).
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
